千亿·国际(中国)唯一官方网站
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2022.05.11
千亿国际:独立董事关于第五届董事会第十九次会议相关事项之事前认可意见
2022.05.11
千亿国际:独立董事关于第五届董事会第十九次会议相关事项的独立意见
2022.05.11
千亿国际:第五届董事会第十九次会议决议公告
2022.05.11
2021 Annual Report
2022.05.11
2021 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
2022.05.10
千亿国际:关于对深圳证券交易所2021年年报问询函回复的公告
2022.05.05
DELAY IN DESPATCH OF 2021 ANNUAL REPORT
2022.05.05
2022 FIRST QUARTERLY REPORT
2022.05.05
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2022.05.05
RESIGNATION OF EXECUTIVE DIRECTOR AND CHANGE OF FINANCIAL CONTROLLER
第一页
上一页
25
26
27
28
29
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.